Abstract Background Intragastric balloons (IGBs) are a minimally invasive option for obesity
treatment, acting as a space-occupying device and leading to weight loss through increased …

Background and Aims: Prior to bariatric surgery, a preoperative weight-reducing regimen is
usually adhered to in most centers. The clinical effects of such a regimen are yet to be …

BACKGROUND More than one-third of US adults are obese. 1 The increasing prevalence of
obesity in the United States has been accompanied by an increasing prevalence in its …

A new paradigm in the treatment of obesity and metabolic disease is developing. The global
obesity epidemic continues to expand despite the availability of diet and lifestyle counseling …

Objectives Therapies less invasive than surgery and more effective than lifestyle and
pharmacotherapy are needed to contend with the obesity epidemic. Intragastric balloons …

Intragastric balloon (IGB) therapy has shown efficacy in weight loss but its role in NAFLD
remains unknown. We conducted a systematic review and meta-analysis to evaluate the …

Bariatric surgery for patients with severe obesity (body mass index (BMI)≥ 50kg/m2) is
technically challenging. Intragastric balloon (IGB) has been proposed for weight loss before …

Several strategies are available to address the obesity epidemic and range from
noninvasive lifestyle interventions to medications and bariatric surgical procedures …

Background Super obesity [body mass index (BMI)> 50 kg/m 2] can yield to higher
morbidity/mortality in bariatric surgery, this could be related to patient's characteristics and/or …

Background: intragastric balloons (IGBs) are a minimally invasive, increasingly popular
option for obesity treatment. However, there is only one worldwide guideline standardizing …